A rare kind of lymphoma in a patient on treatment with two different biological agents

1Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

In this article, we present a rare case of cutaneous pseudolymphoma which developed after treatment with two biologics: infliximab and rituximab. Cutaneous pseudolymphoma should be considered in the differential diagnosis of B- or T-cell lymphoma, which may present not only with local lesions, but also systemic features like fever, weight loss, night sweating, fatigue, and tiredness. In our case, skin biopsy with immunohistochemistry confirmed diagnosis of cutaneous pseudolymphoma. Treatment with systemic corticosteroids was effective.

Cite

CITATION STYLE

APA

Arstikyte, I., Butrimiene, I., Petrulioniene, A., & Venalis, A. (2015). A rare kind of lymphoma in a patient on treatment with two different biological agents. Archives of Rheumatology, 30(1), 75–78. https://doi.org/10.5606/ArchRheumatol.2015.4383

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free